Patrick M Brunner
Overview
Explore the profile of Patrick M Brunner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1911
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peeva E, Guttman-Yassky E, Yamaguchi Y, Berman B, Oemar B, Ramakrishna J, et al.
Drug Discov Today
. 2025 Feb;
30(3):104317.
PMID: 39986647
Evolving research landscapes warrant updates in drug development strategy. Collaborations between pharmaceutical industry and academic institutions are crucial for accelerating drug development, leveraging individual expertise in clinical trial conduct and...
2.
Guttman-Yassky E, Renert-Yuval Y, Brunner P
Lancet
. 2025 Feb;
405(10478):583-596.
PMID: 39955121
Atopic dermatitis is the most common chronic inflammatory skin disease globally. Key features include an eczematous eruption accompanied by intense itch, which can have an enormous negative effect on patients'...
3.
Meledathu S, Naidu M, Brunner P
J Allergy Clin Immunol
. 2025 Jan;
PMID: 39855361
Atopic dermatitis is the most common chronic inflammatory skin condition. This review highlights most recent advances in understanding and treating this debilitating disease. We summarize new insights regarding molecular endotypes...
4.
Bar J, Del Duca E, David E, Bose S, Chefitz G, Brunner P, et al.
Allergy
. 2025 Jan;
PMID: 39760239
Introduction: Chronic hand eczema (CHE) is a highly prevalent inflammatory skin condition which is often resistant to conventional treatments. Molecular insights of CHE remain limited. Tape stripping combined with high-throughput...
5.
Chennareddy S, Rindler K, Meledathu S, Naidu M, Alkon N, Ruggiero J, et al.
J Allergy Clin Immunol
. 2024 Dec;
155(3):892-908.
PMID: 39694280
Background: Chronic erythroderma is a potentially life-threatening condition that can be caused by various diseases, but approximately 30% of cases remain idiopathic, often with insufficient treatment options. Objective: We sought...
6.
Li R, Strobl J, Poyner E, Balbaa A, Torabi F, Mazin P, et al.
Nat Immunol
. 2024 Dec;
26(1):147.
PMID: 39622949
No abstract available.
7.
Li R, Strobl J, Poyner E, Balbaa A, Torabi F, Mazin P, et al.
Nat Immunol
. 2024 Nov;
25(12):2320-2330.
PMID: 39558094
Cutaneous T cell lymphoma (CTCL) is a potentially fatal clonal malignancy of T cells primarily affecting the skin. The most common form of CTCL, mycosis fungoides, can be difficult to...
8.
Port L, Brunner P
Dermatol Clin
. 2024 Sep;
42(4):619-623.
PMID: 39278715
Atopic hand dermatitis (AHD), a manifestation of atopic dermatitis, can have a profound negative effect on a patient's disease-related quality of life due to its visibility, chronic nature, and overall...
9.
Alkon N, Chennareddy S, Cohenour E, Ruggiero J, Stingl G, Bangert C, et al.
J Allergy Clin Immunol
. 2024 Sep;
155(2):461-478.
PMID: 39278361
Background: Mycosis fungoides (MF), the most common cutaneous T-cell lymphoma, is often underdiagnosed in early stages because of similarities with benign dermatoses such as atopic dermatitis (AD). Furthermore, the delineation...
10.
Chennareddy S, Brunner P
J Allergy Clin Immunol
. 2024 Sep;
155(3):800-802.
PMID: 39260791
No abstract available.